PNC Financial Services Group
JAZZ icon

PNC Financial Services Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

PNC Financial Services Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
5,707
+174
+3% +$30.4K ﹤0.01% 1269
2025
Q4 		$941K Buy
5,533
+5
+0.1% +$767 ﹤0.01% 1288
2025
Q3 		$729K Buy
5,528
+15
+0.3% +$1.8K ﹤0.01% 1418
2025
Q2 		$585K Buy
5,513
+385
+8% +$41.8K ﹤0.01% 1451
2025
Q1 		$637K Buy
5,128
+379
+8% +$49.4K ﹤0.01% 1369
2024
Q4 		$585K Buy
4,749
+374
+9% +$44.1K ﹤0.01% 1437
2024
Q3 		$487K Sell
4,375
-386
-8% -$42.3K ﹤0.01% 1551
2024
Q2 		$508K Buy
4,761
+698
+17% +$76.7K ﹤0.01% 1474
2024
Q1 		$489K Buy
4,063
+410
+11% +$50.2K ﹤0.01% 1549
2023
Q4 		$449K Sell
3,653
-1,154
-24% -$144K ﹤0.01% 1586
2023
Q3 		$622K Sell
4,807
-2,737
-36% -$365K ﹤0.01% 1357
2023
Q2 		$935K Sell
7,544
-2,409
-24% -$324K ﹤0.01% 1184
2023
Q1 		$1.46M Sell
9,953
-437
-4% -$64.6K ﹤0.01% 975
2022
Q4 		$1.66M Sell
10,390
-475
-4% -$69.6K ﹤0.01% 933
2022
Q3 		$1.45M Sell
10,865
-175
-2% -$26.6K ﹤0.01% 966
2022
Q2 		$1.72M Buy
11,040
+80
+0.7% +$12.3K ﹤0.01% 938
2022
Q1 		$1.71M Sell
10,960
-634
-5% -$92K ﹤0.01% 1000
2021
Q4 		$1.48M Sell
11,594
-3,369
-23% -$443K ﹤0.01% 1077
2021
Q3 		$1.95M Sell
14,963
-985
-6% -$149K ﹤0.01% 922
2021
Q2 		$2.83M Sell
15,948
-62
-0.4% -$10.7K ﹤0.01% 809
2021
Q1 		$2.63M Sell
16,010
-74
-0.5% -$12.2K ﹤0.01% 789
2020
Q4 		$2.65M Sell
16,084
-143
-0.9% -$21.3K ﹤0.01% 764
2020
Q3 		$2.31M Sell
16,227
-4,873
-23% -$604K ﹤0.01% 759
2020
Q2 		$2.33M Sell
21,100
-75,145
-78% -$8.31M ﹤0.01% 746
2020
Q1 		$9.6M Buy
96,245
+86,560
+894% +$11.2M 0.01% 418
2019
Q4 		$1.45M Sell
9,685
-5,049
-34% -$687K ﹤0.01% 929
2019
Q3 		$1.89M Sell
14,734
-258
-2% -$34.6K ﹤0.01% 1003
2019
Q2 		$2.14M Sell
14,992
-65
-0.4% -$8.73K ﹤0.01% 989
2019
Q1 		$2.15M Sell
15,057
-38,742
-72% -$5.05M ﹤0.01% 1012
2018
Q4 		$6.67M Sell
53,799
-663
-1% -$98.4K 0.01% 593
2018
Q3 		$9.16M Sell
54,462
-68
-0.1% -$11.7K 0.01% 564
2018
Q2 		$9.39M Buy
54,530
+43,209
+382% +$7.06M 0.01% 551
2018
Q1 		$1.71M Sell
11,321
-1,036
-8% -$152K ﹤0.01% 1089
2017
Q4 		$1.66M Sell
12,357
-841
-6% -$117K ﹤0.01% 1112
2017
Q3 		$1.93M Sell
13,198
-638
-5% -$96.5K ﹤0.01% 1035
2017
Q2 		$2.15M Sell
13,836
-1,766
-11% -$270K ﹤0.01% 982
2017
Q1 		$2.26M Sell
15,602
-3,271
-17% -$426K ﹤0.01% 965
2016
Q4 		$2.06M Sell
18,873
-5,290
-22% -$589K ﹤0.01% 983
2016
Q3 		$2.93M Sell
24,163
-2,972
-11% -$401K ﹤0.01% 823
2016
Q2 		$3.83M Sell
27,135
-9,693
-26% -$1.43M ﹤0.01% 707
2016
Q1 		$4.81M Sell
36,828
-28,229
-43% -$3.51M 0.01% 647
2015
Q4 		$9.14M Sell
65,057
-32,384
-33% -$4.49M 0.01% 499
2015
Q3 		$12.9M Sell
97,441
-3,519
-3% -$606K 0.02% 452
2015
Q2 		$17.8M Sell
100,960
-11,475
-10% -$2.06M 0.02% 404
2015
Q1 		$19.4M Sell
112,435
-8,300
-7% -$1.42M 0.02% 382
2014
Q4 		$19.8M Sell
120,735
-3,521
-3% -$584K 0.02% 373
2014
Q3 		$19.9M Sell
124,256
-13,640
-10% -$2.1M 0.02% 365
2014
Q2 		$20.3M Sell
137,896
-329,450
-70% -$45.7M 0.03% 354
2014
Q1 		$64.8M Sell
467,346
-208,835
-31% -$31.4M 0.09% 183
2013
Q4 		$85.6M Buy
676,181
+27,046
+4% +$2.8M 0.11% 141
2013
Q3 		$59.7M Buy
649,135
+624,403
+2,525% +$50.4M 0.09% 179
2013
Q2 		$1.7M Buy
+24,732
New +$1.51M ﹤0.01% 830

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

PNC Financial Services Group's JAZZ Position: Q1 2026 in Review

PNC Financial Services Group increased its Jazz Pharmaceuticals (JAZZ) stake by 3.1% in Q1 2026, buying an estimated $30.4K and bringing the position to 5,707 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

PNC Financial Services Group first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.6M in Q4 2013. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • PNC Financial Services Group held 5,707 shares of Jazz Pharmaceuticals worth $1.08M as of Q1 2026.
  • PNC Financial Services Group bought 174 Jazz Pharmaceuticals shares in Q1 2026, an estimated $30.4K.
  • Jazz Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #1269 holding.
  • PNC Financial Services Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Jazz Pharmaceuticals position peaked at $85.6M in Q4 2013.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.